Regularisation of Mr. Basant Shrivastava as an Independent Director
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanjivani Paranteral Ltd has informed BSE that shareholders, through a postal ballot completed on 5th December 2025, have approved the appointment of Mr. Basant Shrivastava (DIN: 02581255) as an Independent Director on the company board. The appointment is for a term of five consecutive years effective from 11th September 2025, and he is not liable to retire by rotation. Mr. Shrivastava is a 69-year-old pharmaceutical veteran with over four decades of experience in sales and marketing, having worked at Johnson & Johnson and founded Vita Pharma Agencies and Vita Bio International Pvt. Ltd. He currently serves as Joint Director at Joint Force Pharma Ltd and holds an MBA from JBIMS and an M.Sc. in Chemistry. He is not related to any existing directors on the board.
This is a routine governance disclosure — adding an experienced pharma industry professional as an independent director is a neutral-to-positive signal for board quality but is unlikely to move the stock price on its own.